Shanghai MicroPort Endovascular MedTech Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 458.8 million compared to CNY 360.65 million a year ago. Revenue was CNY 458.8 million compared to CNY 362.27 million a year ago.

Net income was CNY 215.04 million compared to CNY 184.7 million a year ago. Basic earnings per share from continuing operations was CNY 2.99 compared to CNY 2.57 a year ago. Diluted earnings per share from continuing operations was CNY 2.99 compared to CNY 2.57 a year ago.